To survey for the presence of infiltrating immune cells in cancer tissue, we measured central immune cell markers (CD8a, CD11c, CD16 and CD68) simultaneously and categorized the present cohort into highly infiltrated (“hot”) tumor and lowly infiltrated (“cold”) tumor samples. The gene discussed is ITGAX; the disease is cancer.